Tag: investment
-
Mobile Diabetes Device Maker Lands $20M in Venture Funds
7 April 2015. Livongo Health, a developer of mobile devices to help people with chronic disorders manage their conditions, raised $20 million in its second venture financing round. Funding for the Mountain View, California start-up, founded 7 months ago, was led by venture capital company Kleiner Perkins Caufield & Byers, with participation from DFJ Ventures and…
-
Bristol-Myers Squibb Licensing Gene Therapies in $2.3B Deal
6 April 2015. Drug maker Bristol-Myers Squibb is licensing gene therapies from biotechnology company uniQure N.V. in a deal with a total potential value of $2.3 billion, including an equity stake in uniQure. The agreement gives Bristol-Myers Squibb exclusive access to as many as 10 disease programs being developed by uniQure, including a treatment for…
-
$150 Million Raised for NYC Life Science Start-Ups
1 April 2015. A consortium of public and private funding sources raised $150 million to invest in new life science companies located in New York City. The Early Stage Life Sciences Funding Initiative exceeded its original $100 million goal by half, and seeks to start 15 to 20 new businesses in New York by 2020,…
-
Novartis, Aduro Biotech Partner on Cancer Immunotherapy
30 March 2015. The pharmaceutical company Novartis is licensing cancer immunotherapy technology from Aduro Biotech in Berkeley, California. The collaboration could earn Aduro as much as $750 million, including an equity stake, for access to its work on cyclic dinucleotides, still in preclinical study, but considered promising as a cancer treatment. Cyclic dinucleotides are naturally…
-
Stem Cell Biotech Gains $44M in First Venture Round
24 March 2015. A biotechnology start-up developing a stem-cell technology to replace missing beta cells that produce insulin for patients with type 1 diabetes, secured $44 million in its first venture funding round. Funding for Semma Therapeutics in Cambridge, Massachusetts was led by MPM Capital, with participation by Fidelity Biosciences, ARCH Venture Partners, and Medtronic.…
-
U.K. Govt, Pharmas Form Dementia Research Fund
17 March 2015. A coalition of the United Kingdom government, five pharmaceutical companies, and the foundation Alzheimer’s Research UK are creating a $100 million fund to finance early research into treatments and cures for dementia. The U.K. health minister Jeremy Hunt is scheduled to unveil the Dementia Discovery Fund at a World Health Organization meeting…
-
Immunotherapy Biotech Raising $45 Million in IPO
12 March 2015. Genocea Biosciences Inc., a biotechnology company developing immunotherapies to treat genital herpes and other diseases, is raising $45 million in its initial public offering of stock. The Cambridge, Massachusetts enterprise is issuing 5,454,545 shares priced at $8.25. The company trades on the NASDAQ exchange under the symbol GNCA. As of 12:00 pm…
-
Gates Invests, Supports R&D in RNA Vaccine Maker
6 March 2015. The Bill and Melinda Gates Foundation is making an equity investment and providing a grant to support research at CureVac GmbH, a developer of vaccines and therapies with RNA molecules. The foundation is investing €46 million ($52 million) in CureVac, in Tübingen, Germany, but the amount of the grant supporting research in…
-
Illumina Adds $40M for Genomic Accelerator Start-Ups
26 February 2015. Illumina Inc., a developer of genomic analysis systems, is adding $40 million for investments in new enterprises based on genomic science that graduate from its accelerator program. The additional financing is provided by Viking Global Investors, an equity and hedge fund investment company in Greenwich, Connecticut. The Illumina Accelerator program provides promising…
-
Redesigned Crutch Developer Gains $450K in Early Funds
17 February 2015. A company developing a more comfortable alternative to standard underarm or forearm crutches, secured $450,000 in its first venture funding round. Financing for Better Walk Inc., a spin-off from Georgia Institute of Technology and based in Atlanta, is led by MB Venture Partners, a Memphis-based venture capital firm. A broken ankle playing basketball…